Skip to main content
. 2016 Dec 21;23(6):e589–e597. doi: 10.3747/co.23.3273

FIGURE 2.

FIGURE 2

Overall survival from diagnosis in 49 patients experiencing crizotinib failure. Patients were censored if no further data were collected (that is, the date of last data collection occurred before death). Median overall survival was 31.6 months in patients experiencing crizotinib failure.